Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Macrogenics (MGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
New Research Coverage Highlights Materialise NV, MacroGenics, GasLog Partners LP, TCP Capital, NantHealth, and Net 1 UEPS Technologies -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Materialise NV (NASDAQ:MTLS),...

MGNX : 22.49 (-0.04%)
UEPS : 9.43 (+0.11%)
TCPC : 14.43 (-0.41%)
GLOP : 23.90 (-0.42%)
MTLS : 13.06 (-1.95%)
NH : 3.22 (-1.83%)
MacroGenics to Present at Jefferies Global Healthcare Conference

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced...

MGNX : 22.49 (-0.04%)
21.2% Return Seen to Date on SmarTrend Macrogenics Inc Call (MGNX)

SmarTrend identified a Downtrend for Macrogenics Inc (NASDAQ:MGNX) on March 27th, 2018 at $25.80. In approximately 2 month, Macrogenics Inc has returned 21.17% as of today's recent price of $20.33.

MGNX : 22.49 (-0.04%)
MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results

MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today provided...

MGNX : 22.49 (-0.04%)
MacroGenics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2018 / MacroGenics, Inc. (NASDAQ: ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 7, 2018 at 4:30:PM Eastern Time.

MGNX : 22.49 (-0.04%)
What's in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens its focus on driving innovation, ramping up production and expanding geographies.

MGNX : 22.49 (-0.04%)
COLL : 26.45 (+0.49%)
ARRY : 17.93 (-0.39%)
PEN : 155.05 (-1.18%)
MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call

MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Monday, May 7, 2018, the Company will release its financial results for the quarter ended March 31, 2018. The Company's management team will host...

MGNX : 22.49 (-0.04%)
Investor Expectations to Drive Momentum within Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp, China Mobile (Hong Kong), MacroGenics, Diodes, CONSOL Coal Resources LP, and Advantage Oil & Gas -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Companhia de saneamento Basico...

CHLKF : 9.0700 (+0.22%)
MGNX : 22.49 (-0.04%)
CCR : 16.00 (-1.54%)
SBS : 6.13 (-1.45%)
CHL : 44.94 (-0.51%)
AAV : 3.05 (-1.61%)
DIOD : 36.58 (+0.05%)
MacroGenics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced...

MGNX : 22.49 (-0.04%)
Shares of Amag Pharmaceuti Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (AMAG , ARWR, MGNX , FPRX , BPMC )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

MGNX : 22.49 (-0.04%)
ARWR : 11.07 (-4.98%)
AMAG : 23.80 (-3.84%)
Macrogenics Inc Shares Up 33.5% Since SmarTrend's Buy Recommendation (MGNX)

SmarTrend identified an Uptrend for Macrogenics Inc (NASDAQ:MGNX) on August 30th, 2017 at $17.83. In approximately 7 months, Macrogenics Inc has returned 33.54% as of today's recent price of $23.81.

MGNX : 22.49 (-0.04%)
MacroGenics Announces Pricing of Public Offering of Common Stock

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced...

MGNX : 22.49 (-0.04%)
SmarTrend Watching for Potential Rebound in Shares of Macrogenics Inc After 12.76% Loss

Macrogenics Inc (NASDAQ:MGNX) traded in a range yesterday that spanned from a low of $25.02 to a high of $28.09. Yesterday, the shares fell 12.8%, which took the trading range below the 3-day low of...

MGNX : 22.49 (-0.04%)
MacroGenics Announces Proposed Public Offering of Common Stock

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced...

MGNX : 22.49 (-0.04%)
Macrogenics Inc Up 64.4% Since SmarTrend Uptrend Call (MGNX)

SmarTrend identified an Uptrend for Macrogenics Inc (NASDAQ:MGNX) on August 30th, 2017 at $17.83. In approximately 7 months, Macrogenics Inc has returned 64.44% as of today's recent price of $29.32.

MGNX : 22.49 (-0.04%)
Consolidated Research: 2018 Summary Expectations for MacroGenics, Radware, Core-Mark Holding, Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp, Atlantic Capital Bancshares, and Alliance Resource Partners -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MacroGenics, Inc. (NASDAQ:MGNX),...

MGNX : 22.49 (-0.04%)
CORE : 20.94 (+1.26%)
SBS : 6.13 (-1.45%)
ACBI : 20.90 (unch)
RDWR : 24.75 (+0.16%)
ARLP : 19.95 (-0.25%)
Macrogenics Inc Has Returned 75.5% Since SmarTrend Recommendation (MGNX)

SmarTrend identified an Uptrend for Macrogenics Inc (NASDAQ:MGNX) on August 30th, 2017 at $17.83. In approximately 7 months, Macrogenics Inc has returned 75.49% as of today's recent price of $31.29.

MGNX : 22.49 (-0.04%)
MacroGenics to Present at Cowen Health Care Conference

MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced...

MGNX : 22.49 (-0.04%)
5 Best ETF Charts of Q4 Earnings

Several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the market rout.

TAN : 23.25 (-3.08%)
MGNX : 22.49 (-0.04%)
FSLR : 51.06 (-4.93%)
FTXL : 34.56 (-0.06%)
SEDG : 47.45 (-7.32%)
JNCE : 7.92 (+1.15%)
CNCR : 26.55 (-0.41%)
XAR : 88.91 (-0.41%)
SPY : 277.13 (-0.57%)
GLD : 121.34 (-1.65%)
IBUY : 52.85 (-0.04%)
NKTR : 57.86 (+2.57%)
5 Best ETF Charts of Q4 Earnings

Several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the market rout.

TAN : 23.25 (-3.08%)
MGNX : 22.49 (-0.04%)
FSLR : 51.06 (-4.93%)
FTXL : 34.56 (-0.06%)
SEDG : 47.45 (-7.32%)
JNCE : 7.92 (+1.15%)
CNCR : 26.55 (-0.41%)
XAR : 88.91 (-0.41%)
SPY : 277.13 (-0.57%)
GLD : 121.34 (-1.65%)
IBUY : 52.85 (-0.04%)
NKTR : 57.86 (+2.57%)

Van Meerten Stock Picks

5 Great Large Caps
This morning I wanted to find 5 Large Cap stocks that had performed well over the last year and still appeared to have some juice left in them.
ABMD +2.93 , NFLX -0.89 , VLO -1.64 , RL +0.62 , ALGN -3.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed with most nearby contracts 1 to 2 cents lower on Friday, despite showing gains at midday. Front month July lost 4.37% on the week. December fell to within 1 1/4 cents of the life of contract low in the overnight session. Managed m...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar